Skip to content
Recall Observatory FDA recall evidence

Drug product

GLUTATHIONE L REDUCED 100MG/ML (2ML NEBVL) INHALATION; GLUTATHIONE L REDUCED 200MG/ML (1ML NEBVL) INHALATION; GLUTATHIONE L REDUCED 220MG/ML (30ML VIAL) INJECTABLE; GLUTATHIONE L REDUCED 500MG/ML (1ML VIAL) INJECTABLE; GLUTATHIONE L REDUCED 500MG/ML (2ML VIAL) INJECTABLE; GLUTATHIONE L REDUCED-PF- 200MG/ML (2ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.

D-0210-2023

December 22, 2022

Class II

Product summary

Firm
Pharmacy Innovations
Event
Event 91332
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0210-2023

Official wording

Reason: Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Code information: t20221129@68 t20221025@32 t20221025@33 t20221114@27 t20221021@40 t20221116@36

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility